These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10482462)

  • 1. 1,3-Disubstituted benzazepines as neuropeptide Y Y1 receptor antagonists.
    Murakami Y; Hagishita S; Okada T; Kii M; Hashizume H; Yagami T; Fujimoto M
    Bioorg Med Chem; 1999 Aug; 7(8):1703-14. PubMed ID: 10482462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,3-Disubstituted benzazepines as novel, potent, selective neuropeptide Y Y1 receptor antagonists.
    Murakami Y; Hara H; Okada T; Hashizume H; Kii M; Ishihara Y; Ishikawa M; Shimamura M; Mihara S; Kato G; Hanasaki K; Hagishita S; Fujimoto M
    J Med Chem; 1999 Jul; 42(14):2621-32. PubMed ID: 10411482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
    Silva AP; Carvalho AP; Carvalho CM; Malva JO
    Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Existence of both neuropeptide Y, Y1 and Y2 receptors in pig spleen: evidence using subtype-selective antagonists in vivo.
    Malmström RE
    Life Sci; 2001 Sep; 69(17):1999-2005. PubMed ID: 11589515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats.
    Gradin KA; Buus CL; Li JY; Frøbert O; Simonsen U
    Br J Pharmacol; 2006 Jul; 148(5):703-13. PubMed ID: 16715120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
    Widdowson PS
    Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Y5-selective radioligand.
    Mullins D; Adham N; Hesk D; Wu Y; Kelly J; Huang Y; Guzzi M; Zhang X; McCombie S; Stamford A; Parker E
    Eur J Pharmacol; 2008 Dec; 601(1-3):1-7. PubMed ID: 18976648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible binding kinetics of neuropeptide Y ligands to Y2 but not to Y1 and Y5 receptors.
    Dautzenberg FM; Neysari S
    Pharmacology; 2005 Dec; 75(1):21-9. PubMed ID: 15908753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.
    Dumont Y; Gaudreau P; Mazzuferi M; Langlois D; Chabot JG; Fournier A; Simonato M; Quirion R
    Br J Pharmacol; 2005 Dec; 146(8):1069-81. PubMed ID: 16231000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
    Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological evaluation of 1229U91, a novel high-affinity and selective neuropeptide Y-Y1 receptor antagonist.
    Hegde SS; Bonhaus DW; Stanley W; Eglen RM; Moy TM; Loeb M; Shetty SG; DeSouza A; Krstenansky J
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1261-6. PubMed ID: 8531090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potent nonpeptide neuropeptide Y Y1 receptor antagonist, a benzodiazepine derivative.
    Shigeri Y; Ishikawa M; Ishihara Y; Fujimoto M
    Life Sci; 1998; 63(11):PL 151-60. PubMed ID: 9747900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenesis of human neuropeptide Y/peptide YY receptor Y2 reveals additional differences to Y1 in interactions with highly conserved ligand positions.
    Akerberg H; Fällmar H; Sjödin P; Boukharta L; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D
    Regul Pept; 2010 Aug; 163(1-3):120-9. PubMed ID: 20471432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
    Gehlert DR; Schober DA; Morin M; Berglund MM
    Biochem Pharmacol; 2007 Dec; 74(11):1652-64. PubMed ID: 17897631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of a series of novel 2-[(4-chlorophenoxy)methyl]benzimidazoles as selective neuropeptide Y Y1 receptor antagonists.
    Zarrinmayeh H; Nunes AM; Ornstein PL; Zimmerman DM; Arnold MB; Schober DA; Gackenheimer SL; Bruns RF; Hipskind PA; Britton TC; Cantrell BE; Gehlert DR
    J Med Chem; 1998 Jul; 41(15):2709-19. PubMed ID: 9667962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, structure, and antagonistic properties of des-Asn29[D-Trp28,32]NPY(27-36).
    Balasubramaniam A; Zhai W; Tao Z; Huang Y; Fischer JE; Eden P; Taylor JE; Kar L; Samarasinghe SD; Johnson ME
    Peptides; 1996; 17(7):1113-8. PubMed ID: 8959744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of substituted 2-cyclohexyl-4-phenyl-1H-imidazoles: potent and selective neuropeptide Y Y5-receptor antagonists.
    Blum CA; Zheng X; De Lombaert S
    J Med Chem; 2004 Apr; 47(9):2318-25. PubMed ID: 15084130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5).
    Dumont Y; Cadieux A; Doods H; Fournier A; Quirion R
    Can J Physiol Pharmacol; 2000 Feb; 78(2):116-25. PubMed ID: 10737674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.